Enliven Therapeutics, Inc.

Q4 2025 13F Holders

Symbol
ELVN
CUSIP
29337E102
Type
Equity
Class
COM
Num filers
128
Total reported value, excl. options
$961M
Manager Report Date Value ($000) Shares Option Type